{"product_id":"plant-pathogen-resistance-biotechnology-9781118867761","title":"Plant Pathogen Resistance Biotechnology","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003ePlant pathogens and diseases are among the most significant challenges to survival that plants face. Disease outbreaks caused by microbial or viral pathogens can decimate crop yields and have severe effects on global food supply.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eList of Contributors xiii\u003c\/p\u003e \u003cp\u003eForeword xix\u003c\/p\u003e \u003cp\u003eAcknowledgments xxv\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1 The Status and Prospects for Biotechnological Approaches for Attaining Sustainable\u003c\/b\u003e \u003cb\u003eDisease Resistance 1\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDavid B. Collinge, Ewen Mullins, Birgit Jensen and Hans J.L. Jørgensen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1.1 Introduction 1\u003c\/p\u003e \u003cp\u003e1.2 Factors to consider when generating disease‐resistant crops 2\u003c\/p\u003e \u003cp\u003e1.3 Opportunities to engineer novel cultivars for disease resistance 10\u003c\/p\u003e \u003cp\u003e1.4 Technical barriers to engineering novel cultivars for disease resistance 13\u003c\/p\u003e \u003cp\u003e1.5 Approaches for identification and selection of genes important for disease resistance 14\u003c\/p\u003e \u003cp\u003e1.6 Promising strategies for engineering disease‐resistant crops 15\u003c\/p\u003e \u003cp\u003e1.7 Future directions and issues 15\u003c\/p\u003e \u003cp\u003eReferences 16\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I: Biological Strategies Leading Towards Disease Resistance 21\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2 Engineering Barriers to Infection by Undermining Pathogen Effector Function or by\u003c\/b\u003e \u003cb\u003eGaining Effector Recognition 23\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAli Abdurehim Ahmed, Hazel McLellan, Geziel Barbosa Aguilar, Ingo Hein, Hans Thordal‐Christensen and Paul R.J. Birch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2.1 Introduction 23\u003c\/p\u003e \u003cp\u003e2.2 Plant defence and effector function 24\u003c\/p\u003e \u003cp\u003e2.3 Strategies for engineering resistance 33\u003c\/p\u003e \u003cp\u003e2.4 Perspective 42\u003c\/p\u003e \u003cp\u003eReferences 43\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3 Application of Antimicrobial Proteins and Peptides in Developing Disease‐Resistant Plants\u003c\/b\u003e \u003cb\u003e51\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAshis Kumar Nandi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3.1 Introduction 51\u003c\/p\u003e \u003cp\u003e3.2 Biological role of PR‐proteins 52\u003c\/p\u003e \u003cp\u003e3.3 Antimicrobial peptides 56\u003c\/p\u003e \u003cp\u003e3.4 Regulation of PR‐protein expression 57\u003c\/p\u003e \u003cp\u003e3.5 Biotechnological application of PR‐protein genes in developing improved crop plants 60\u003c\/p\u003e \u003cp\u003e3.6 Future directions 61\u003c\/p\u003e \u003cp\u003eAcknowledgement 63\u003c\/p\u003e \u003cp\u003eReferences 63\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4 Metabolic Engineering of Chemical Defence Pathways in Plant Disease Control 71\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eFred Rook\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4.1 Introduction 71\u003c\/p\u003e \u003cp\u003e4.2 Present status of metabolic engineering in the control of plant disease 73\u003c\/p\u003e \u003cp\u003e4.3 Metabolic engineering: technical challenges and opportunities 78\u003c\/p\u003e \u003cp\u003e4.4 The outlook for metabolically engineering of disease resistance in crops 83\u003c\/p\u003e \u003cp\u003eReferences 85\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5 Arabinan: Biosynthesis and a Role in Host‐Pathogen Interactions 91\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMaria Stranne and Yumiko Sakuragi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5.1 Introduction 91\u003c\/p\u003e \u003cp\u003e5.2 Biosynthesis and modification of arabinan 94\u003c\/p\u003e \u003cp\u003e5.3 Distribution of arabinan in different tissues and during development 96\u003c\/p\u003e \u003cp\u003e5.4 Role of arabinan in plant growth and development 98\u003c\/p\u003e \u003cp\u003e5.5 Roles of arabinan degrading enzymes in virulence of phytopathogenic fungi 99\u003c\/p\u003e \u003cp\u003e5.6 Roles of arabinan in pathogen interactions 101\u003c\/p\u003e \u003cp\u003e5.7 Conclusion 103\u003c\/p\u003e \u003cp\u003eReferences 103\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6 Transcription Factors that Regulate Defence Responses and Their Use in Increasing\u003c\/b\u003e \u003cb\u003eDisease Resistance 109\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePrateek Tripathi, Aravind Galla, Roel C. Rabara and Paul J. Rushton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6.1 Introduction 109\u003c\/p\u003e \u003cp\u003e6.2 Transcription factors and plant defence 110\u003c\/p\u003e \u003cp\u003e6.3 AP2\/ERF transcription factors 111\u003c\/p\u003e \u003cp\u003e6.4 bZIP transcription factors 113\u003c\/p\u003e \u003cp\u003e6.5 WRKY transcription factors 114\u003c\/p\u003e \u003cp\u003e6.6 MYB transcription factors 116\u003c\/p\u003e \u003cp\u003e6.7 Other transcription factor families 117\u003c\/p\u003e \u003cp\u003e6.8 Can the manipulation of specific transcription factors deliver sustainable disease resistance? 118\u003c\/p\u003e \u003cp\u003e6.9 Have we chosen the right transgenes? 119\u003c\/p\u003e \u003cp\u003e6.10 Have we chosen the right expression strategies? 120\u003c\/p\u003e \u003cp\u003e6.11 What new ideas are there for the future of TF‐based crop improvement? 121\u003c\/p\u003e \u003cp\u003eReferences 124\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7 Regulation of Abiotic and Biotic Stress Responses by Plant Hormones 131\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDominik K. Großkinsky, Eric van der Graaff and Thomas Roitsch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7.1 Introduction 131\u003c\/p\u003e \u003cp\u003e7.2 Regulation of biotic stress responses by plant hormones 132\u003c\/p\u003e \u003cp\u003e7.3 Regulation of abiotic stress responses by plant hormones 140\u003c\/p\u003e \u003cp\u003e7.4 Conclusions and further perspectives 145\u003c\/p\u003e \u003cp\u003eReferences 147\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II: Case Studies for Groups of Pathogens and Important Crops. Why is it Especially Advantageous\u003c\/b\u003e \u003cb\u003eto use Transgenic Strategies for these Pathogens or Crops? 155\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8 Engineered Resistance to Viruses: A Case of Plant Innate Immunity 157\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePaula Tennant and Marc Fuchs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8.1 Introduction 157\u003c\/p\u003e \u003cp\u003e8.2 Mitigation of viruses 158\u003c\/p\u003e \u003cp\u003e8.3 Biotechnology and virus resistance 158\u003c\/p\u003e \u003cp\u003e8.4 Success stories 162\u003c\/p\u003e \u003cp\u003e8.5 Challenges of engineering RNAi‐mediated resistance 163\u003c\/p\u003e \u003cp\u003e8.6 Benefits of virus‐resistant transgenic crops 164\u003c\/p\u003e \u003cp\u003e8.7 Conclusions 166\u003c\/p\u003e \u003cp\u003eReferences 167\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 9 Problematic Crops: 1. Potatoes: Towards Sustainable Potato Late Blight Resistance by\u003c\/b\u003e \u003cb\u003eCisgenic \u003ci\u003eR \u003c\/i\u003eGene Pyramiding 171\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eKwang‐Ryong Jo, Suxian Zhu, Yuling Bai, Ronald C.B. Hutten, G.J. Kessel, Vivianne G.A.A. Vleeshouwers, Evert Jacobsen, Richard G.F. Visser and Jack H. Vossen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9.1 Potato late blight resistance breeding advocates GM strategies 171\u003c\/p\u003e \u003cp\u003e9.2 GM strategies for late blight resistance breeding 177\u003c\/p\u003e \u003cp\u003e9.3 Late blight‐resistant GM varieties 186\u003c\/p\u003e \u003cp\u003eReferences 187\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 10 Problematic Crops: 1. Grape: To Long Life and Good Health: Untangling the Complexity of\u003c\/b\u003e \u003cb\u003eGrape Diseases to Develop Pathogen‐Resistant Varieties 193\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDario Cantu, M. Caroline Roper, Ann L.T. Powell and John M. Labavitch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10.1 Introduction 193\u003c\/p\u003e \u003cp\u003e10.2 Introduction to grapevine pathology 194\u003c\/p\u003e \u003cp\u003e10.3 Approaches for the improvement of grapevine disease resistance 198\u003c\/p\u003e \u003cp\u003e10.4 Pierce’s disease of grapevines: a case study 202\u003c\/p\u003e \u003cp\u003eReferences 211\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 11 Developing Sustainable Disease Resistance in Coffee: Breeding vs. Transgenic Approaches\u003c\/b\u003e \u003cb\u003e217\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAvinash Kumar, Simmi P. Sreedharan, Nandini P. Shetty and Giridhar Parvatam\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11.1 Introduction 217\u003c\/p\u003e \u003cp\u003e11.2 Agronomic aspects of coffee 217\u003c\/p\u003e \u003cp\u003e11.3 Major threats to coffee plantations 219\u003c\/p\u003e \u003cp\u003e11.4 Breeding for disease resistance and pest management 225\u003c\/p\u003e \u003cp\u003e11.5 Various traits targeted for transgenic coffee development 227\u003c\/p\u003e \u003cp\u003e11.6 Bottlenecks in coffee transgenic development 229\u003c\/p\u003e \u003cp\u003e11.7 GM or hybrid joe: what choices to make? 235\u003c\/p\u003e \u003cp\u003eAcknowledgements 236\u003c\/p\u003e \u003cp\u003eEndnote 236\u003c\/p\u003e \u003cp\u003eReferences 236\u003c\/p\u003e \u003cp\u003eWebliographies 243\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 12 Biotechnological Approaches for Crop Protection: Transgenes for Disease Resistance in\u003c\/b\u003e \u003cb\u003eRice 245\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBlanca San Segundo, Belén Lopez‐García and María Coca\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12.1 Introduction 245\u003c\/p\u003e \u003cp\u003e12.2 Plant immunity 247\u003c\/p\u003e \u003cp\u003e12.3 Transgenic approaches to engineer disease resistance in rice plants 250\u003c\/p\u003e \u003cp\u003e12.4 Targeted genome engineering 260\u003c\/p\u003e \u003cp\u003e12.5 Safety issues of genetically engineered rice 261\u003c\/p\u003e \u003cp\u003e12.6 Conclusions and future prospects 263\u003c\/p\u003e \u003cp\u003eAcknowledgement 265\u003c\/p\u003e \u003cp\u003eReferences 265\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III: Status of Transgenic Crops Around the World 273\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 13 Status of Transgenic Crops in Argentina 275\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eFernando F. Bravo‐Almonacid and María Eugenia Segretin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13.1 Transgenic crops approved for commercialization in Argentina 275\u003c\/p\u003e \u003cp\u003e13.2 Economic impact derived from transgenic crops cultivation 278\u003c\/p\u003e \u003cp\u003e13.3 Local developments 278\u003c\/p\u003e \u003cp\u003e13.4 Perspectives 282\u003c\/p\u003e \u003cp\u003eReferences 282\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 14 The Status of Transgenic Crops in Australia 285\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichael Gilbert\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14.1 Introduction 285\u003c\/p\u003e \u003cp\u003e14.2 Government policies 286\u003c\/p\u003e \u003cp\u003e14.3 Field trials 287\u003c\/p\u003e \u003cp\u003e14.4 Crops deregulated 287\u003c\/p\u003e \u003cp\u003e14.5 Crops grown 287\u003c\/p\u003e \u003cp\u003e14.6 Public sentiment toward GM crops 291\u003c\/p\u003e \u003cp\u003e14.7 Value capture 291\u003c\/p\u003e \u003cp\u003e14.8 What is in the pipeline 292\u003c\/p\u003e \u003cp\u003e14.9 Summary 292\u003c\/p\u003e \u003cp\u003eEndnotes 293\u003c\/p\u003e \u003cp\u003eReferences 293\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 15 Transgenic Crops in Spain 295\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMaría Coca, Belén Lopez‐García and Blanca San Segundo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15.1 Introduction 295\u003c\/p\u003e \u003cp\u003e15.2 Transgenic crops in Europe 296\u003c\/p\u003e \u003cp\u003e15.3 Transgenic crops in Spain 297\u003c\/p\u003e \u003cp\u003e15.4 Future prospects 300\u003c\/p\u003e \u003cp\u003eAcknowledgements 302\u003c\/p\u003e \u003cp\u003eReferences 302\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 16 Biotechnology and Crop Disease Resistance in South Africa 305\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMaryke Carstens and Dave K. Berger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16.1 Genetically modified crops in South Africa 305\u003c\/p\u003e \u003cp\u003e16.2 Economic, social and health benefits of GM crops in South Africa 308\u003c\/p\u003e \u003cp\u003e16.3 Biotechnology initiatives for crop disease control in South Africa 309\u003c\/p\u003e \u003cp\u003e16.4 Future prospects 312\u003c\/p\u003e \u003cp\u003eAcknowledgements 313\u003c\/p\u003e \u003cp\u003eReferences 313\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV: Implications of Transgenic Technologies for Improved Disease Control 317\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 17 Exploiting Plant Induced Resistance as a Route to Sustainable Crop Protection 319\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eMichael R. Roberts and Jane E. Taylor\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17.1 Introduction 319\u003c\/p\u003e \u003cp\u003e17.2 Examples of elicitors of induced resistance 321\u003c\/p\u003e \u003cp\u003e17.3 Priming of induced resistance 326\u003c\/p\u003e \u003cp\u003e17.4 Drivers and barriers to the adoption of plant activators in agriculture and horticulture 330\u003c\/p\u003e \u003cp\u003e17.5 Conclusions and future prospects 334\u003c\/p\u003e \u003cp\u003eReferences 334\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 18 Biological Control Using Microorganisms as an Alternative to Disease Resistance 341\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDan Funck Jensen, Magnus Karlsson, Sabrina Sarrocco and Giovanni Vannacci\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18.1 Introduction 341\u003c\/p\u003e \u003cp\u003e18.2 Getting the right biocontrol organism 343\u003c\/p\u003e \u003cp\u003e18.3 New approaches for studying the biology of BCAs and biocontrol interactions 351\u003c\/p\u003e \u003cp\u003e18.4 Strategy for using biocontrol in IPM 354\u003c\/p\u003e \u003cp\u003eReferences 357\u003c\/p\u003e \u003cp\u003eWebliography 363\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 19 TILLING in Plant Disease Control: Applications and Perspectives 365\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eFrancesca Desiderio, Anna Maria Torp, Giampiero Valè and Søren K. Rasmussen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19.1 Concepts of forward and reverse genetics 365\u003c\/p\u003e \u003cp\u003e19.2 The TILLING procedure 366\u003c\/p\u003e \u003cp\u003e19.3 Mutagenesis 366\u003c\/p\u003e \u003cp\u003e19.4 DNA preparation and pooling of individuals 371\u003c\/p\u003e \u003cp\u003e19.5 Mutation discovery 372\u003c\/p\u003e \u003cp\u003e19.6 Identification and evaluation of the individual mutant 374\u003c\/p\u003e \u003cp\u003e19.7 Bioinformatics tools 374\u003c\/p\u003e \u003cp\u003e19.8 EcoTILLING 375\u003c\/p\u003e \u003cp\u003e19.9 Modified TILLING approaches 375\u003c\/p\u003e \u003cp\u003e19.10 Application of TILLING and TILLING‐related procedures in disease resistance 376\u003c\/p\u003e \u003cp\u003e19.11 Perspectives 380\u003c\/p\u003e \u003cp\u003eReferences 381\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 20 Fitness Costs of Pathogen Recognition in Plants and Their Implications for Crop\u003c\/b\u003e \u003cb\u003eImprovement 385\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJames K.M. Brown\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20.1 The goal of durable resistance 385\u003c\/p\u003e \u003cp\u003e20.2 New ways of using \u003ci\u003eR\u003c\/i\u003e‐genes 386\u003c\/p\u003e \u003cp\u003e20.3 Costs of resistance in crop improvement 387\u003c\/p\u003e \u003cp\u003e20.4 Fitness costs of \u003ci\u003eR\u003c\/i\u003e‐gene defences 388\u003c\/p\u003e \u003cp\u003e20.5 Phenotypes of \u003ci\u003eR\u003c\/i\u003e‐gene over‐expression 390\u003c\/p\u003e \u003cp\u003e20.6 Requirements for \u003ci\u003eR\u003c\/i\u003e‐protein function 391\u003c\/p\u003e \u003cp\u003e20.7 Necrotic phenotypes of \u003ci\u003eR\u003c\/i\u003e‐gene mutants 394\u003c\/p\u003e \u003cp\u003e20.8 Summary of fitness costs of \u003ci\u003eR\u003c\/i\u003e‐gene mutations 396\u003c\/p\u003e \u003cp\u003e20.9 \u003ci\u003eR\u003c\/i\u003e‐genes in plant breeding 397\u003c\/p\u003e \u003cp\u003e20.10 Biotech innovation and genetic diversity 400\u003c\/p\u003e \u003cp\u003e20.11 Conclusion 400\u003c\/p\u003e \u003cp\u003eAcknowledgement 400\u003c\/p\u003e \u003cp\u003eReferences 400\u003c\/p\u003e \u003cp\u003eIndex 405\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":53515637129559,"sku":"9781118867761","price":156.56,"currency_code":"GBP","in_stock":true}],"url":"https:\/\/bookcurl.com\/products\/plant-pathogen-resistance-biotechnology-9781118867761","provider":"Book Curl","version":"1.0","type":"link"}